Provided by Tiger Fintech (Singapore) Pte. Ltd.

Essex Property

270.89
-4.4000-1.60%
Post-market: 270.890.00000.00%16:33 EDT
Volume:253.56K
Turnover:68.55M
Market Cap:17.43B
PE:23.47
High:274.72
Open:272.30
Low:267.22
Close:275.29
Loading ...

NVX: Believe Current Trade Situation Highlights Need for Local Supply Chain for Battery Materials

Zacks Small Cap Research
·
Yesterday

RBC Adjusts Price Target on Essex Property Trust to $311 From $315, Maintains Outperform Rating

MT Newswires Live
·
17 Apr

Essex Property Trust Inc : RBC Cuts Target Price to $311 From $315

THOMSON REUTERS
·
17 Apr

3 Residential REITs Worth Considering Amid Market Headwinds

Zacks
·
16 Apr

Is it Wise to Retain Essex Property Stock in Your Portfolio Now?

Zacks
·
14 Apr

Essex Property Is Maintained at Equal-Weight by Barclays

Dow Jones
·
12 Apr

Essex Property Trust price target lowered to $303 from $304 at Barclays

TIPRANKS
·
11 Apr

Evercore ISI Adjusts Price Target on Essex Property Trust to $283 From $302, Keeps In Line Rating

MT Newswires Live
·
10 Apr

Navitas & GigaDevice Announce Partnership to Combine Power & Control for Next-Gen, High-Frequency, High-Efficiency, & High-Density Power Platforms

GlobeNewswire
·
09 Apr

ESS Tech (GWH) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Zacks
·
07 Apr

Press Release: Essex Announces Release and Conference Call Dates for Its First Quarter 2025 Earnings

Dow Jones
·
05 Apr

Can Residential REITs Bounce Back on Solid Demand in Early '25?

Zacks
·
05 Apr

Essex Property Updates YTD Portfolio Reallocation Activity

Zacks
·
05 Apr

JPMorgan Adjusts Price Target on Essex Property Trust to $309 From $303, Keeps Underweight Rating

MT Newswires Live
·
04 Apr

ESS Tech Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
04 Apr

Essex Property Trust Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
04 Apr

Essex Property Trust Announces Recent Transaction Activity

Business Wire
·
04 Apr

Why Shares of Axsome Therapeutics Slumped Today

Motley Fool
·
02 Apr

ESS Recognized as TIME Top GreenTech Company and one of Fortune’s Most Innovative Companies in America for 2025

Business Wire
·
01 Apr

Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025

GlobeNewswire
·
01 Apr